Drug labels

ISNTREE HYALURONIC ACID DAILY SUNGEL

AVOBENZONE, HOMOSALATE, OCTISALATE · ISNTREE Inc. · TOPICAL

HUMAN OTC DRUG
Open FDA's page for this record
Set ID
5a3a17ff-a7fd-f707-e063-6394a90a3182
ID
5a3a1884-c8be-f786-e063-6394a90acdbb
Effective time
20260829
Version
1
SPL product data elements

ISNTREE HYALURONIC ACID DAILY SUNGEL Avobenzone, Homosalate, Octisalate HOMOSALATE HOMOSALATE AVOBENZONE AVOBENZONE OCTISALATE OCTISALATE POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) XANTHAN GUM ADENOSINE DIETHYLHEXYL 2,6-NAPHTHALATE NIACINAMIDE CETYL ALCOHOL SILICON DIOXIDE PROPANEDIOL HYALURONIC ACID SODIUM PALMITOYL PROLINE GLYCERIN ETHYLHEXYLGLYCERIN SODIUM ACETYLATED HYALURONATE BUTYLENE GLYCOL DIMETHYLSILANOL HYALURONATE HYALURONATE SODIUM C20-22 ALCOHOLS TOCOPHEROL DIPROPYLENE GLYCOL PENTYLENE GLYCOL TROMETHAMINE CENTELLA ASIATICA TRITERPENOIDS HOUTTUYNIA CORDATA FLOWERING TOP PURSLANE ECTOINE WATER GLYCERYL MONOSTEARATE AMMONIUM ACRYLOYLDIMETHYLTAURATE, DIMETHYLACRYLAMIDE, LAURYL METHACRYLATE AND LAURETH-4 METHACRYLATE COPOLYMER, TRIMETHYLOLPROPANE TRIACRYLATE CROSSLINKED (45000 MPA.S) NYMPHAEA ALBA FLOWER BUTYLOCTYL SALICYLATE C20-22 ALKYL PHOSPHATE 1,2-HEXANEDIOL

Active ingredient
Active ingredients Avobenzone 2.7 % Homosalate 9 % Octisalate 4.5 %
Purpose
Purpose sunscreen
Indications and usage

Uses • helps prevent sunburn • higher SPF gives more sunburn protection • if used as directed with other sun protection measures ( see Directions ) decreases the risk of skin cancer and early skin aging caused by the sun

Warnings
Warnings For external use only.
Do not use
Do not use • on damaged skin or broken skin.
When using
When using this product • keep out of eyes. Rinse with water to remove.
Stop use
Stop use and ask a doctor if •rash or irritation develops and lasts.
Keep out of reach of children
Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.
Dosage and administration

Directions ■ apply liberally 15 minutes before sun exposure. Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: • limit time in the sun, especially from 10 a.m. - 2 p.m. • wear long-sleeved shirts, pants, hats, and sunglasses ■ children under 6 months of age: Ask a doctor ■ reapply at least every 2 hours. ■ use a water-resistant sunscreen if swimming or sweating.

Other safety information

Other information ■ protect the product from exessive heat and direct sun ■ Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risks of skin aging, skin cancer, and other harmful effects of the sun.

Inactive ingredient

Inactive ingredients Water, Butyloctyl Salicylate, Butylene Glycol, Diethylhexyl 2,6-Naphthalate, Niacinamide, C20-22 Alkyl Phosphate, C20-22 Alcohols, 1,2-Hexanediol, Pentylene Glycol, Acrylates Copolymer, Polymethylsilsesquioxane, Cetyl Alcohol, Poly C10-30 Alkyl Acrylate, VP/Eicosene Copolymer, Glyceryl Stearate, Silica, Tromethamine, Propanediol, Polyacrylate Crosspolymer-6, Xanthan Gum, Ethylhexylglycerin, Adenosine, Portulaca Oleracea Extract, Centella Asiatica Extract, Houttuynia Cordata Extract, Hydrolyzed Hyaluronic Acid, Hydrolyzed Sodium Hyaluronate, Dimethylsilanol Hyaluronate, Hyaluronic Acid, Sodium Hyaluronate, Potassium Hyaluronate, Sodium Hyaluronate Crosspolymer, Hydroxypropyltrimonium Hyaluronate, Sodium Hyaluronate Dimethylsilanol, Sodium Acetylated Hyaluronate, Tocopherol, Ectoin, Dipropylene Glycol, Sodium Palmitoyl Proline, Glycerin, Beta-Glucan, Nymphaea Alba Flower Extract

Package label principal display panel
ISNTREE HYALURONIC ACID DAILY SUN JEL 10ml ISNTREE HYALURONIC ACID DAILY SUN JEL 10ml
Harmonized identifiers (openFDA)
Application number
M020
Brand name
ISNTREE HYALURONIC ACID DAILY SUNGEL
Generic name
AVOBENZONE, HOMOSALATE, OCTISALATE
Manufacturer name
ISNTREE Inc.
Product NDC
81100-104
Product type
HUMAN OTC DRUG
Route
TOPICAL
Substance name
HOMOSALATE, AVOBENZONE, OCTISALATE
SPL ID
5a3a1884-c8be-f786-e063-6394a90acdbb
SPL set ID
5a3a17ff-a7fd-f707-e063-6394a90a3182
Package NDC
81100-104-01, 81100-104-02
Is original packager
true
UNII
V06SV4M95S, G63QQF2NOX, 4X49Y0596W
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.